HEAT SHOCK PROTEIN 90 INHIBITOR NVP-AUY922 EXERTS POTENT ACTIVITY AGAINST ADULT T-CELL LEUKEMIA-LYMPHOMA CELLS

被引：0
|
作者：
Taniguchi, H. [1 ]
Hasegawa, H. [2 ]
Sasaki, D. [2 ]
Mori, S. [2 ]
Ando, K. [1 ]
Sawayama, Y. [1 ]
Imanishi, D. [1 ]
Taguchi, J. [1 ]
Imaizumi, Y. [1 ]
Hata, T. [1 ]
Tsukasaki, K. [3 ]
Yanagihara, K. [2 ]
Mori, N. [4 ]
Miyazaki, Y. [1 ]
机构：
[1] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki 852, Japan
[2] Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan
[3] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba, Japan
[4] Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, Okinawa, Japan
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1780
引用
收藏
页码：684 / 685
页数：2
相关论文
共 50 条
  • [1] Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells
    Taniguchi, Hiroaki
    Hasegawa, Hiroo
    Sasaki, Daisuke
    Ando, Koji
    Sawayama, Yasushi
    Imanishi, Daisuke
    Taguchi, Jun
    Imaizumi, Yoshitaka
    Hata, Tomoko
    Tsukasaki, Kunihiro
    Uno, Naoki
    Morinaga, Yoshitomo
    Yanagihara, Katsunori
    Miyazaki, Yasushi
    CANCER SCIENCE, 2014, 105 (12) : 1601 - 1608
  • [2] Activity of new heat shock protein 90 (hsp90) inhibitor NVP-AUY922 against myeloma cells sensitive and resistant to conventional agents
    McMillin, Douglas W.
    Negri, Joseph
    Delmore, Jake
    Hayden, Patrick
    Ooi, Melissa
    Mitsiades, Nicholas
    Schlossman', Robert
    Richardson, Paul G.
    Munshi, Nikhil C.
    Jensen, Michael R.
    Quadt, Cornelia
    Chene, Patrick
    Schoepfer, Joseph
    Garcia-Echeverria, Carlos
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BLOOD, 2007, 110 (11) : 474A - 474A
  • [3] NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
    Eccles, Suzanne A.
    Massey, Andy
    Raynaud, Florence I.
    Sharp, Swee Y.
    Box, Gary
    Valenti, Melanie
    Patterson, Lisa
    Brandon, Alexis de Haven
    Gowan, Sharon
    Boxall, Frances
    Aherne, Wynne
    Rowlands, Martin
    Hayes, Angela
    Martins, Vanessa
    Urban, Frederique
    Boxall, Kathy
    Prodromou, Chrisostomos
    Pearl, Laurence
    James, Karen
    Matthews, Thomas P.
    Cheung, Kwai-Ming
    Kalusa, Andrew
    Jones, Keith
    McDonald, Edward
    Barril, Xavier
    Brough, Paul A.
    Cansfield, Julie E.
    Dymock, Brian
    Drysdale, Martin J.
    Finch, Harry
    Howes, Rob
    Hubbard, Roderick E.
    Surgenor, Alan
    Webb, Paul
    Wood, Mike
    Wright, Lisa
    Workman, Paul
    CANCER RESEARCH, 2008, 68 (08) : 2850 - 2860
  • [4] Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen
    Tauchi, T.
    Okabe, S.
    Ashihara, E.
    Kimura, S.
    Maekawa, T.
    Ohyashiki, K.
    ONCOGENE, 2011, 30 (24) : 2789 - 2797
  • [5] Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen
    T Tauchi
    S Okabe
    E Ashihara
    S Kimura
    T Maekawa
    K Ohyashiki
    Oncogene, 2011, 30 : 2789 - 2797
  • [6] Synergistic Action of Heat-Shock Protein-90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition
    Kaiser, M.
    Lamottke, B.
    Jensen, M. R.
    Quadt, C.
    Garcia-Echeverria, C.
    Mieth, M.
    Heider, U.
    Sezer, O.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S129 - S129
  • [7] Combined Effects of Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib against Mutant Forms of BCR-ABL
    Tauchi, Tetsuzo
    Akahane, Daigo
    Okabe, Sciichi
    Ashihara, Eishi
    Kimura, Shinya
    Maekawa, Taira
    Ohyashiki, Kazuma
    BLOOD, 2008, 112 (11) : 269 - 269
  • [8] Combined Effects of novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib in a Random Mutagenesis Screen.
    Tauchi, Tetsuzo
    Okabe, Seiichi
    Ashihara, Eishi
    Kimura, Shinya
    Maekawa, Taira
    Ohyashiki, Kazuma
    BLOOD, 2009, 114 (22) : 1449 - 1449
  • [9] Heat-shock protein (Hsp) 70 inhibition enhances the effect of the Hsp90 inhibitor NVP-AUY922 on melanoma cells
    Yeramian, A.
    Vea, A.
    Santacana, M.
    Matias-Guiu, X.
    Marti, R. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E48 - E48
  • [10] The novel HSP90 inhibitor NVP-AUY922 demonstrates activity in rhabdomyosarcoma cell lines
    Slater, O.
    Renshaw, J.
    Workman, P.
    Pritchard-Jones, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 593 - 593
12345